These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1587543)

  • 21. Current issues in the development of a vaccine against HIV infection.
    Davey RT
    Ear Nose Throat J; 1990 Jul; 69(7):497-505. PubMed ID: 2205474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Human immunodeficiency virus (HIV): a review].
    Schulz TF; Larcher C; Dierich MP
    Z Hautkr; 1990 Jul; 65(7):619-22, 625-6, 629-32. PubMed ID: 2205059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine approaches currently in development.
    Gold D
    Body Posit; 1998 Jul; 11(7):34-5. PubMed ID: 11365616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIV infection of macaques: a model for AIDS vaccine development.
    Gardner MB
    Dev Biol Stand; 1990; 72():259-66. PubMed ID: 2178124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological considerations in the development of a human immunodeficiency virus vaccine.
    Nathanson N; Mathieson BJ
    J Infect Dis; 2000 Aug; 182(2):579-89. PubMed ID: 10915092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV vaccine development: past, present and future.
    Robb ML
    IDrugs; 2010 Dec; 13(12):852-6. PubMed ID: 21154142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The quest for an AIDS vaccine: the state of the art and current challenges.
    Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):425-33. PubMed ID: 1873078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for the development of vaccines against HIV.
    Minor PD
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():55-62. PubMed ID: 2654115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine development for HIV infection.
    Bolognesi D
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1295-9. PubMed ID: 2362019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mucosal immune system: from control of inflammation to protection against infections.
    Kaiserlian D; Cerf-Bensussan N; Hosmalin A
    J Leukoc Biol; 2005 Aug; 78(2):311-8. PubMed ID: 15894590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 immunogen.
    Lein B
    PI Perspect; 1995 May; (no 16):17. PubMed ID: 11362424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and trials of AIDS vaccines.
    Sonigo P; Girard M; Dormont D
    Immunol Today; 1990 Dec; 11(12):465-71. PubMed ID: 2073319
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine based on dendritic cells.
    AIDS Patient Care STDS; 1999 Apr; 13(4):249. PubMed ID: 10351899
    [No Abstract]   [Full Text] [Related]  

  • 38. The Question of HIV Vaccine: Why Is a Solution Not Yet Available?
    Libera M; Caputo V; Laterza G; Moudoud L; Soggiu A; Bonizzi L; Diotti RA
    J Immunol Res; 2024; 2024():2147912. PubMed ID: 38628675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caution required in developing HIV vaccine.
    Rabinoff M
    Med Hypotheses; 1990 Feb; 31(2):155-6. PubMed ID: 2325588
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV vaccine research: Hope for renaissance.
    Hum Vaccin; 2010 Aug; 6(9):. PubMed ID: 20930536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.